NEU 0.48% $20.97 neuren pharmaceuticals limited

Share Price, page-10802

  1. 6 Posts.
    lightbulb Created with Sketch. 1
    I think Tangentland is correct that Daybue sales is a key driver.
    If Daybue has a strong quarter it will give the market confidence in ongoing revenue/profit and can be used to calculated a base for the SP going fwd.
    Also it will support the narrative of NEU being able to fund any P3 trials themselves
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.97
Change
0.100(0.48%)
Mkt cap ! $2.679B
Open High Low Value Volume
$20.96 $21.28 $20.91 $990.2K 47.10K

Buyers (Bids)

No. Vol. Price($)
8 292 $20.95
 

Sellers (Offers)

Price($) Vol. No.
$20.97 49 4
View Market Depth
Last trade - 10.51am 24/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.